Thomas Stranzl

Title: The Innovations of Thomas Stranzl

Introduction

Thomas Stranzl is a notable inventor based in Farum, Denmark. He has made significant contributions to the field of allergy immunotherapy through his innovative research and patents. His work focuses on immunogenic proteins derived from allergenic mites, which have the potential to improve diagnostic methods and treatment options for allergies.

Latest Patents

Stranzl holds a patent for "Immunogenic proteins and fragments thereof from allergenic mites." This invention relates to novel immunogenic polypeptides identified in house dust mites and storage mites. These polypeptides can be utilized in allergy immunotherapy and for diagnostic purposes, particularly in the production of antibodies that bind to the polypeptide or in characterizing allergen extracts from these mites.

Career Highlights

Throughout his career, Thomas Stranzl has worked with prominent organizations, including Alk-Abelló, Inc. and the La Jolla Institute for Allergy and Immunology. His experience in these institutions has allowed him to advance his research and contribute to the understanding of allergenic responses.

Collaborations

Stranzl has collaborated with notable professionals in his field, including Bjoern Peters and Gitte Lund. These partnerships have further enriched his research and innovation efforts.

Conclusion

Thomas Stranzl's work in the field of allergy immunotherapy exemplifies the impact of innovative research on health and diagnostics. His contributions through patents and collaborations continue to influence the development of effective allergy treatments.